158 related articles for article (PubMed ID: 21515509)
21. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
22. Levetiracetam: a new therapeutic option for refractory epilepsy.
Pinto A; Sander JW
Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam for seizure prevention in brain tumor patients: a systematic review.
Nasr ZG; Paravattil B; Wilby KJ
J Neurooncol; 2016 Aug; 129(1):1-13. PubMed ID: 27168191
[TBL] [Abstract][Full Text] [Related]
24. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury.
Bakr A; Belli A
Br J Neurosurg; 2018 Jun; 32(3):237-244. PubMed ID: 29688078
[TBL] [Abstract][Full Text] [Related]
26. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
27. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
Cereghino JJ; Biton V; Abou-Khalil B; Dreifuss F; Gauer LJ; Leppik I
Neurology; 2000 Jul; 55(2):236-42. PubMed ID: 10908898
[TBL] [Abstract][Full Text] [Related]
28. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
30. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
Tan J; Paquette V; Levine M; Ensom MHH
Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
[TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
Ben-Menachem E; Falter U
Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
[TBL] [Abstract][Full Text] [Related]
33. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.
Chaari A; Mohamed AS; Abdelhakim K; Kauts V; Casey WF
Int J Clin Pharm; 2017 Oct; 39(5):998-1003. PubMed ID: 28780739
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Rosati A; Ilvento L; Lucenteforte E; Pugi A; Crescioli G; McGreevy KS; Virgili G; Mugelli A; De Masi S; Guerrini R
Epilepsia; 2018 Feb; 59(2):297-314. PubMed ID: 29270989
[TBL] [Abstract][Full Text] [Related]
36. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
Gidal BE; Baltès E; Otoul C; Perucca E
Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
38. Levetiracetam in refractory pediatric epilepsy.
Wheless JW; Ng YT
J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
[TBL] [Abstract][Full Text] [Related]
39. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.
Leppik IE; Biton V; Sander JW; Wieser HG
Epilepsia; 2003 Dec; 44(12):1585-7. PubMed ID: 14636332
[TBL] [Abstract][Full Text] [Related]
40. Melatonin as add-on treatment for epilepsy.
Brigo F; Del Felice A
Cochrane Database Syst Rev; 2012 Jun; (6):CD006967. PubMed ID: 22696363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
